Filter

Refine by date

—

Refine by collections

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 382 items for :

  • glucagon-like peptide-1 x
  • Refine by access: Content accessible to me x
Clear All
Thomas H Claus Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Thomas H Claus in
Google Scholar
PubMed Close
,
Clark Q Pan Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Clark Q Pan in
Google Scholar
PubMed Close
,
Joanne M Buxton Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Joanne M Buxton in
Google Scholar
PubMed Close
,
Ling Yang Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Ling Yang in
Google Scholar
PubMed Close
,
Jennifer C Reynolds Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Jennifer C Reynolds in
Google Scholar
PubMed Close
,
Nicole Barucci Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Nicole Barucci in
Google Scholar
PubMed Close
,
Michael Burns Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Michael Burns in
Google Scholar
PubMed Close
,
Astrid A Ortiz Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Astrid A Ortiz in
Google Scholar
PubMed Close
,
Steve Roczniak Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Steve Roczniak in
Google Scholar
PubMed Close
,
James N Livingston Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by James N Livingston in
Google Scholar
PubMed Close
,
Kevin B Clairmont Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by Kevin B Clairmont in
Google Scholar
PubMed Close
, and
James P Whelan Bayer HealthCare, Pharmaceuticals, Department of Metabolic Disease Research, 400 Morgan Lane, West Haven, Connecticut 06516 USA
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA

Search for other papers by James P Whelan in
Google Scholar
PubMed Close

Introduction Glucagon-like peptide-1 (GLP-1) is a potent endogenous modulator of insulin secretion that is released by the L-cells in the crypts of the jejunum and ileum in response to a meal ( Kieffer & Habener 1999 ). Its function

Article Type:
Research Article
DOI:
https://doi.org/10.1677/JOE-06-0018
Volume/Issue:
Volume 192: Issue 2
Free access
L van Bloemendaal
Search for other papers by L van Bloemendaal in
Google Scholar
PubMed Close
,
J S ten Kulve
Search for other papers by J S ten Kulve in
Google Scholar
PubMed Close
,
S E la Fleur Diabetes Centre, Department of Endocrinology and Metabolism, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands

Search for other papers by S E la Fleur in
Google Scholar
PubMed Close
,
R G Ijzerman
Search for other papers by R G Ijzerman in
Google Scholar
PubMed Close
, and
M Diamant
Search for other papers by M Diamant in
Google Scholar
PubMed Close

), oxyntomodulin (OXM) and glucagon-like peptide 1 (GLP-1), have been identified as players in the regulation of feeding by relaying meal-related information on nutritional status to the brain. Based on more than three decades of experimental evidence from rodent

Article Type:
Review Article
DOI:
https://doi.org/10.1530/JOE-13-0414
Volume/Issue:
Volume 221: Issue 1
Free access
Guillaume Mabilleau GEROM Groupe Etudes Remodelage Osseux et biomatériaux, IRIS-IBS Institut de Biologie en Santé, CHU d’Angers, Université d’Angers, Angers, France

Search for other papers by Guillaume Mabilleau in
Google Scholar
PubMed Close
,
Marie Pereira Centre for Complement and Inflammation Research (CCIR), Department of Medicine, Imperial College London, London, UK

Search for other papers by Marie Pereira in
Google Scholar
PubMed Close
, and
Chantal Chenu Department of Comparative Biomedical Sciences, Royal Veterinary College, London, UK

Search for other papers by Chantal Chenu in
Google Scholar
PubMed Close

needed, to reach an HbA 1C level of 7% or less. Among the most prescribed drugs, the glucagon-like peptide-1 receptor agonists (GLP-1RAs) have recently attracted attention as Glp-1r -knockout animals, and GLP-1-supplemented animals exhibited

Article Type:
Review Article
DOI:
https://doi.org/10.1530/JOE-17-0278
Volume/Issue:
Volume 236: Issue 1
Free access
Antonella Amato
Search for other papers by Antonella Amato in
Google Scholar
PubMed Close
,
Sara Baldassano
Search for other papers by Sara Baldassano in
Google Scholar
PubMed Close
,
Rosa Liotta Laboratorio di Fisiologia Generale, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT), Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Viale delle Scienze, 90128 Palermo, Italy

Search for other papers by Rosa Liotta in
Google Scholar
PubMed Close
,
Rosa Serio
Search for other papers by Rosa Serio in
Google Scholar
PubMed Close
, and
Flavia Mulè
Search for other papers by Flavia Mulè in
Google Scholar
PubMed Close

Introduction Glucagon-like peptide 1 (GLP1), produced by intestinal enteroendocrine L-cells in response to the ingestion of nutrients ( Schirra et al . 1996 ), is highly insulinotropic and an inhibitor of gastrointestinal motility, effects that

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-13-0525
Volume/Issue:
Volume 221: Issue 1
Free access
Guillaume Mabilleau Groupe d'Etudes sur le Remodelage Osseux et les bioMatériaux (GEROM) – LHEA, Service Commun d'Imageries
et d'Analyses Microscopiques (SCIAM), School of Biomedical Sciences
Groupe d'Etudes sur le Remodelage Osseux et les bioMatériaux (GEROM) – LHEA, Service Commun d'Imageries
et d'Analyses Microscopiques (SCIAM), School of Biomedical Sciences

Search for other papers by Guillaume Mabilleau in
Google Scholar
PubMed Close
,
Aleksandra Mieczkowska Groupe d'Etudes sur le Remodelage Osseux et les bioMatériaux (GEROM) – LHEA, Service Commun d'Imageries
et d'Analyses Microscopiques (SCIAM), School of Biomedical Sciences

Search for other papers by Aleksandra Mieczkowska in
Google Scholar
PubMed Close
,
Nigel Irwin Groupe d'Etudes sur le Remodelage Osseux et les bioMatériaux (GEROM) – LHEA, Service Commun d'Imageries
et d'Analyses Microscopiques (SCIAM), School of Biomedical Sciences

Search for other papers by Nigel Irwin in
Google Scholar
PubMed Close
,
Peter R Flatt Groupe d'Etudes sur le Remodelage Osseux et les bioMatériaux (GEROM) – LHEA, Service Commun d'Imageries
et d'Analyses Microscopiques (SCIAM), School of Biomedical Sciences

Search for other papers by Peter R Flatt in
Google Scholar
PubMed Close
, and
Daniel Chappard Groupe d'Etudes sur le Remodelage Osseux et les bioMatériaux (GEROM) – LHEA, Service Commun d'Imageries
et d'Analyses Microscopiques (SCIAM), School of Biomedical Sciences
Groupe d'Etudes sur le Remodelage Osseux et les bioMatériaux (GEROM) – LHEA, Service Commun d'Imageries
et d'Analyses Microscopiques (SCIAM), School of Biomedical Sciences

Search for other papers by Daniel Chappard in
Google Scholar
PubMed Close

al . 2010 ). Glucagon-like peptide-1 (GLP1) is a gut hormone synthesized and secreted into the blood stream by intestinal endocrine L cells in response to a variety of stimuli ( Wu et al . 2010 ). Biologically active GLP1 is secreted as a 7–37 or 7

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-13-0146
Volume/Issue:
Volume 219: Issue 1
Free access
Shou-Si Lu
Search for other papers by Shou-Si Lu in
Google Scholar
PubMed Close
,
Yun-Li Yu
Search for other papers by Yun-Li Yu in
Google Scholar
PubMed Close
,
Hao-Jie Zhu Key Lab of Drug Metabolism and Pharmacokinetics, Department of Pharmaceutical and Biomedical Science, China Pharmaceutical University, Nanjing 210009, People's Republic of China

Search for other papers by Hao-Jie Zhu in
Google Scholar
PubMed Close
,
Xiao-Dong Liu
Search for other papers by Xiao-Dong Liu in
Google Scholar
PubMed Close
,
Li Liu
Search for other papers by Li Liu in
Google Scholar
PubMed Close
,
Yao-Wu Liu
Search for other papers by Yao-Wu Liu in
Google Scholar
PubMed Close
,
Ping Wang
Search for other papers by Ping Wang in
Google Scholar
PubMed Close
,
Lin Xie
Search for other papers by Lin Xie in
Google Scholar
PubMed Close
, and
Guang-Ji Wang
Search for other papers by Guang-Ji Wang in
Google Scholar
PubMed Close

play is an important role in the regulation of endocrine pancreatic secretion. The intestinal products of the proglucagon gene, glucagon-like peptide-1 (GLP-1), has been shown to contribute significantly to the overall insulin response to oral glucose

Article Type:
Research Article
DOI:
https://doi.org/10.1677/JOE-08-0419
Volume/Issue:
Volume 200: Issue 2
Free access
Jun-ichi Eiki Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan
Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Jun-ichi Eiki in
Google Scholar
PubMed Close
,
Kaori Saeki Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Kaori Saeki in
Google Scholar
PubMed Close
,
Norihiro Nagano Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Norihiro Nagano in
Google Scholar
PubMed Close
,
Tomoharu Iino Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Tomoharu Iino in
Google Scholar
PubMed Close
,
Mari Yonemoto Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Mari Yonemoto in
Google Scholar
PubMed Close
,
Yoko Takayenoki-Iino Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Yoko Takayenoki-Iino in
Google Scholar
PubMed Close
,
Satoru Ito Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Satoru Ito in
Google Scholar
PubMed Close
,
Teruyuki Nishimura Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Teruyuki Nishimura in
Google Scholar
PubMed Close
,
Yoshiyuki Sato Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Yoshiyuki Sato in
Google Scholar
PubMed Close
,
Makoto Bamba Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Makoto Bamba in
Google Scholar
PubMed Close
,
Hitomi Watanabe Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Hitomi Watanabe in
Google Scholar
PubMed Close
,
Kaori Sasaki Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Kaori Sasaki in
Google Scholar
PubMed Close
,
Sumika Ohyama Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Sumika Ohyama in
Google Scholar
PubMed Close
,
Akio Kanatani Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Akio Kanatani in
Google Scholar
PubMed Close
,
Toshio Nagase Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Toshio Nagase in
Google Scholar
PubMed Close
, and
Toshihiko Yada Tsukuba Research Institute, Division of Integrative Physiology, Banyu Pharmaceutical Co., Ltd, 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan

Search for other papers by Toshihiko Yada in
Google Scholar
PubMed Close

Introduction Glucagon-like peptide-1 (GLP-1) is a hormone secreted from enteroendocrine L-cells, and is well recognized as an incretin that induces insulin secretion in a glucose-dependent manner ( Drucker 2006 ). The functions of GLP-1 have been

Article Type:
Research Article
DOI:
https://doi.org/10.1677/JOE-08-0528
Volume/Issue:
Volume 201: Issue 3
Free access
Can Liu Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Can Liu in
Google Scholar
PubMed Close
,
Mian Zhang Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Mian Zhang in
Google Scholar
PubMed Close
,
Meng-yue Hu Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Meng-yue Hu in
Google Scholar
PubMed Close
,
Hai-fang Guo Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Hai-fang Guo in
Google Scholar
PubMed Close
,
Jia Li Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Jia Li in
Google Scholar
PubMed Close
,
Yun-li Yu Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Yun-li Yu in
Google Scholar
PubMed Close
,
Shi Jin Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Shi Jin in
Google Scholar
PubMed Close
,
Xin-ting Wang Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Xin-ting Wang in
Google Scholar
PubMed Close
,
Li Liu Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Li Liu in
Google Scholar
PubMed Close
, and
Xiao-dong Liu Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Search for other papers by Xiao-dong Liu in
Google Scholar
PubMed Close

, it is noteworthy that local high concentration of ginsenosides in intestine may interact with intestinal epithelium, where numerous endocrine cells are located. Glucagon-like peptide-1 (GLP1), secreted by enteroendocrine L-cells, is one of the most

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-12-0502
Volume/Issue:
Volume 217: Issue 2
Free access
Mi-Hyun Kim
Search for other papers by Mi-Hyun Kim in
Google Scholar
PubMed Close
,
Jae-Hwan Jee Division of Endocrinology and Metabolism, Division of Endocrinology and Metabolism, Samsung Biomedical Research Institute, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea

Search for other papers by Jae-Hwan Jee in
Google Scholar
PubMed Close
,
Sunyoung Park
Search for other papers by Sunyoung Park in
Google Scholar
PubMed Close
,
Myung-Shik Lee Division of Endocrinology and Metabolism, Division of Endocrinology and Metabolism, Samsung Biomedical Research Institute, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea

Search for other papers by Myung-Shik Lee in
Google Scholar
PubMed Close
,
Kwang-Won Kim Division of Endocrinology and Metabolism, Division of Endocrinology and Metabolism, Samsung Biomedical Research Institute, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea

Search for other papers by Kwang-Won Kim in
Google Scholar
PubMed Close
, and
Moon-Kyu Lee Division of Endocrinology and Metabolism, Division of Endocrinology and Metabolism, Samsung Biomedical Research Institute, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea

Search for other papers by Moon-Kyu Lee in
Google Scholar
PubMed Close

Introduction Glucagon-like peptide (GLP)-1 is an intestinal hormone that exerts its effects in the regulation of glucose metabolism, the stimulation of pancreatic insulin secretion, proinsulin gene expression, and the proliferation and anti

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-13-0381
Volume/Issue:
Volume 220: Issue 2
Free access
Hongbin Liu Eastern Clinical Research Unit, Department of Diabetes and Endocrinology, Biotechnology Division, Monash University, 6th Floor Burnett Tower, 89 Commercial Road, Prahran 3181, Melbourne, Victoria, Australia
Eastern Clinical Research Unit, Department of Diabetes and Endocrinology, Biotechnology Division, Monash University, 6th Floor Burnett Tower, 89 Commercial Road, Prahran 3181, Melbourne, Victoria, Australia

Search for other papers by Hongbin Liu in
Google Scholar
PubMed Close
,
Yunshan Hu Eastern Clinical Research Unit, Department of Diabetes and Endocrinology, Biotechnology Division, Monash University, 6th Floor Burnett Tower, 89 Commercial Road, Prahran 3181, Melbourne, Victoria, Australia
Eastern Clinical Research Unit, Department of Diabetes and Endocrinology, Biotechnology Division, Monash University, 6th Floor Burnett Tower, 89 Commercial Road, Prahran 3181, Melbourne, Victoria, Australia

Search for other papers by Yunshan Hu in
Google Scholar
PubMed Close
,
Richard W Simpson Eastern Clinical Research Unit, Department of Diabetes and Endocrinology, Biotechnology Division, Monash University, 6th Floor Burnett Tower, 89 Commercial Road, Prahran 3181, Melbourne, Victoria, Australia
Eastern Clinical Research Unit, Department of Diabetes and Endocrinology, Biotechnology Division, Monash University, 6th Floor Burnett Tower, 89 Commercial Road, Prahran 3181, Melbourne, Victoria, Australia

Search for other papers by Richard W Simpson in
Google Scholar
PubMed Close
, and
Anthony E Dear Eastern Clinical Research Unit, Department of Diabetes and Endocrinology, Biotechnology Division, Monash University, 6th Floor Burnett Tower, 89 Commercial Road, Prahran 3181, Melbourne, Victoria, Australia
Eastern Clinical Research Unit, Department of Diabetes and Endocrinology, Biotechnology Division, Monash University, 6th Floor Burnett Tower, 89 Commercial Road, Prahran 3181, Melbourne, Victoria, Australia

Search for other papers by Anthony E Dear in
Google Scholar
PubMed Close

Introduction Glucagon-like peptide-1 (GLP-1), an incretin first identified in 1984, has been proposed as a potential candidate target for therapy in the treatment of type 2 diabetes ( Nauck et al . 1993 , Edwards 2005 ). GLP-1, the product of the

Article Type:
Research Article
DOI:
https://doi.org/10.1677/JOE-07-0387
Volume/Issue:
Volume 196: Issue 1
Free access